alexa Medicinal Plants as a Safe Target for Treatment of Cancer | Open Access Journals
ISSN: 2329-6836
Natural Products Chemistry & Research
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Medicinal Plants as a Safe Target for Treatment of Cancer

*Khaled Nabih Rashed
Pharmacognosy Department, National Research Centre, Dokki, Giza, Egypt
Corresponding Author : Khaled Nabih Rashed
Pharmacognosy Department
National Research Centre
Dokki, Giza, Egypt
Tel: 01003642233
E-mail: [email protected]
Received January 16, 2014; Accepted January 18, 2014; Published January 20, 2014
Citation: Rashed KN (2014) Medicinal Plants as a Safe Target for Treatment of Cancer. Nat Prod Chem Res 2:e106. doi: 10.4172/2329-6836.1000e106
Copyright: © 2014 Rashed KN. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Related article at
DownloadPubmed DownloadScholar Google

Visit for more related articles at Natural Products Chemistry & Research

Anticancer; Medicinal plants; Herbal medicine; Cancer treatment
Cancer is a major public health burden in both developed and developing countries. It was estimated that there were 10.9 million new cases, 6.7 million deaths, and 24.6 million persons living with cancer around the world in 2012 [1-3]. Natural products especially plants have been used for the treatment of various diseases for thousands of years. The Ebers Papyrus, the best known Egyptian pharmaceutical record which documented over 700 drugs, represents the history of Egyptian medicine dated from 1500 BC. The Chinese Materia Medica, which describes more than 600 medicinal plants, has been well documented with the first record dating from about 1100 BC. [4]. Many medicinal plants have anti-cancer activity as Allium sativum contains more than 100 biologically useful secondary metabolites, which include alliin, alliinase, allicin, Sallyl- cysteine (SAC), Diallyl disulphide (DADS).
Diallyl trisulphide (DATS) and Methylallyl trisulphides [5]. Annona species contain acetogenins, which possess significant cytotoxic activity against leukaemia and sarcoma. Acetogenins are found to be effective in the treatment of nasopharyngeal carcinoma [6]. Arctium lappa contains potent anticancer factors that prevent mutations in the oncogenes. It has been used in the treatment of malignant melanoma, lymphoma and cancers of the pancreas, breast, ovary, oesophagus, bladder, bile duct and the bone. A study revealed that it reduces the size of tumour, relieves the pain and prolongs the survival period [7]. Gossypium barbadense contains gossypol. Recent studies have revealed that gossypol possesses selective toxicity towards cancerous cells [8]. Gyrophora esculenta is a mushroom that inhibits growth of cancer by enhancing activity of the natural killer cells. A study revealed that it inhibits carcinogenesis and metastases [8]. Egypt, a semi- arid region has abundant plants resources, which are traditionally used for various disorders. Some Egyptian flora are used as anticancer agents as Luffa aegyptiaca (sponge gourd), Solenostemma arghe (argel), Cassia italica (senegal senna), Ocimum basillcum (basil), Colocasia antiguorum (taro), Beta vulgaris (beet) and fruit of Capsicum frutescens (chili pepper). Anticancer activities of these plants were observed in vitro against acute myeloid leukemia (AML) and acute lymphocyte leukemia (ALL); and in vivo against Ehrlich as cites carcinoma cells (EACC). Solenostemma arghel hot water extract significantly reduced EACC induced tumor growth and delayed animal death (with EACC) by 29 days. Among all the extracts S. arghel showed high cytotoxicity (66-90%) on ALL and AML cells from patients [9].

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

Article Usage

  • Total views: 11715
  • [From(publication date):
    March-2014 - Aug 21, 2017]
  • Breakdown by view type
  • HTML page views : 7902
  • PDF downloads :3813

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version